Back

Temporal trends in guideline-directed medical therapy prescription and 30-day readmission after heart failure hospitalization

13 May 2024 (09:00 - 10:00)
Organised by: Logo
Congress Presentation Part of: ePosters in acute heart failure 12 Pharmacotherapy HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Renzo Laborante

South General Hospital, Stockholm (Sweden)

7 More presentations in this session

Presentation thumbnail
Unlocking stability: predictors of clinical stability in patients undergoing intermittent levosimendan infusions for advanced heart failure
Doctor F. Gerardo (Amadora, PT)
Abstract Slides Video
Presentation thumbnail
Adherence to quadruple therapy for heart failure. A single-center experience in LMIC
Doctor A. Khan (Peshawar, PK)
Abstract Slides Video
Presentation thumbnail
Impact on hospitalisation and safety of high doses of torasemide in advanced or end-stage decompensated heart failure
Doctor T. Castiello (London, GB)
Abstract Slides Video
Presentation thumbnail
Potential cardio-protective role of dapagliflozin in diabetic patients presented with anterior ST-elevation myocardial infarction (STEMI).
Associate Professor A. Ibrahim (Aswan, EG)
Abstract Slides Video
Presentation thumbnail
Use of guideline-directed medical therapy in women hospitalised for decompensated heart failure
Doctor T. Furlan (Trbovlje, SI)
Abstract Slides Video

Access the full session

Session thumbnail
ePosters in acute heart failure 12

The Event

Event poster

Heart Failure 2024

13 May 2024 09:00 CET
You may be interested in
thumbnail
Congress Presentation
Temporal trends in guideline-recommended medical therapy after an acute heart failure decompensation event: an observational analysis from Generator Heart Failure DataMart
thumbnail
Congress Presentation
Did we forget ARNI in the era of SGLTi?
thumbnail
Congress Presentation
Initiation and titration of prognostic drug therapy during hospitalization for acute decompensation of heart failure with reduced ejection fraction

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources